Ország: Japán
Nyelv: angol
Forrás: すりの適正使用協議会 RAD-AR Council, Japan
Insulin glargine (genetical recombination) [insulin glargine biosimilar 2]
FUJIFILM Toyama Chemical Co., Ltd.
Insulin glargine (genetical recombination) [insulin glargine biosimilar 2]
limpid and colorless injection
Drug Information Sheet("Kusuri-no-Shiori") Self-injection Revised: 03/2019 The information on this sheet is based on approvals granted by the Japanese regulatory authority. Approval details may vary by country. Medicines have adverse reactions (risks) as well as efficacies (benefits). It is important to minimize adverse reactions and maximize efficacy. To obtain a better therapeutic response, patients should understand their medication and cooperate with the treatment. BRAND NAME: INSULIN GLARGINE BS INJECTION KIT[FFP] ACTIVE INGREDIENT: Insulin glargine (genetical recombination) [insulin glargine biosimilar 2] DOSAGE FORM: limpid and colorless injection IMPRINT OR PRINT ON WRAPPING: EFFECTS OF THIS MEDICINE This medicine lowers blood glucose levels by glucose uptake into cells, inhibiting glucose production in the liver and promoting glycogen synthesis in the liver and the muscle.It is usually used to treat diabetes mellitus for which insulin therapy is indicated. THE FOLLOWING PATIENTS MAY NEED TO BE CAREFUL WHEN USING THIS MEDICINE.BE SURE TO TELL YOUR DOCTOR AND PHARMACIST. ・If you have previously experienced any allergic reactions (itch, rash, etc.) to any medicines or foods. If you have: hypoglycemic symptoms, gastrointestinal disorder such as diarrhea and vomiting, insufficient dietary intake due to cold etc. ・If you are pregnant or breastfeeding. ・If you are taking any other medicinal products. (Some medicines may interact to enhance or diminish medicinal effects. Beware of over-the-counter medicines and dietary supplements as well as other prescription medicines.) DOSING SCHEDULE (HOW TO TAKE THIS MEDICINE) ・ Your dosing schedule prescribed by your doctor is(( to be written by a healthcare professional )) ・In general, for adults, in the early phase, subcutaneously inject 4 to 20 units once a day. In some cases, this medicine may be used in combination with other insulin preparations. The timing of injection should be either before breakfast or at bedti Olvassa el a teljes dokumentumot